HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carbon dioxide automated digital subtraction angiography for endovascular arteriovenous fistulas creation.

Abstract
Recent literature shows how residual renal function (RKF), defined as the urinary clearance of urea and creatinine, is associated with a lower mortality risk in HD patients. The use of non-nephrotoxic contrast media during radiological procedure, may be useful for preservation of RKF in patients with chronic kidney disease not yet in haemodialysis. We describe the case of a 51-year-old male suffering from chronic kidney disease from 2018, due to a right nephrectomy for an adenocarcinoma, who was considered for an endovascular arteriovenous fistula (endoAVF) creation (WavelinQ endoAVF System, Becton Dickinson, Franklin Lakes, New Jersey, US), using Carbon Dioxide as contrast media instead of conventional iodinated ones, with optimal results. CO2 DSA permits to well recognize the patency of target vein, its connection to the perforator vein and finally the endoAVF creation without requiring supplemental iodate contrast medium. We propose, CO2 automated digital subtraction angiography (DSA) as a safer technique that could be substitutive of the standard iodinated ones, in the creation of endo AVF.
AuthorsMatteo Tozzi, Marco Franchin, Federico Fontana, Filippo Piacentino, Angela Veneziano, Paola Muscato, Giovanni Leati, Gabriele Piffaretti
JournalThe journal of vascular access (J Vasc Access) Vol. 25 Issue 2 Pg. 633-636 (Mar 2024) ISSN: 1724-6032 [Electronic] United States
PMID36196011 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carbon Dioxide
  • Contrast Media
Topics
  • Male
  • Humans
  • Middle Aged
  • Angiography, Digital Subtraction
  • Carbon Dioxide
  • Contrast Media
  • Arteriovenous Fistula (etiology)
  • Endovascular Procedures (adverse effects)
  • Renal Insufficiency, Chronic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: